ClinicaliQ Trial Snapshot
- Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT07636642.
- What is being tested: A sixth-generation high-sensitivity cardiac troponin T assay evaluated in a controlled before-and-after study design to determine its ability to safely and rapidly rule out myocardial infarction in clinical practice.
- Patient eligibility overview: The trial includes patients presenting with suspected acute myocardial infarction who require cardiac troponin testing, comparing outcomes before and after implementation of the new sixth-generation assay in routine clinical care.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Cardiac troponin is a protein released into the blood when the heart muscle is damaged. Measuring this protein helps doctors diagnose a heart attack (also called a myocardial infarction). Modern blood tests, known as high-sensitivity cardiac troponin assays, can detect very small amounts of this protein. A new version of this test, called Troponin T high-sensitivity Gen 6, has recently been developed and approved for use. It is designed to be more accurate and reliable, detecting smaller changes in troponin levels and being less affected by technical interference. The investigators…
Eligibility Snapshot
- : * Age 18 years and over. * Attending clinician suspects acute coronary syndrome. * At least one measurement of cardiac troponin using the Gen 5 or Gen 6 hs-cTnT assay.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.